Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

Some individuals continue to experience myopia progression into adulthood and may benefit from myopia control therapies. Although most individuals experience myopia stabilization during adulthood, ...